Basic Information
Edunn Biotechnology is a biotechnology company dedicated to developing oligonucleotide drugs for the treatment of central nervous system diseases. The company has developed a drug, ol-1, for treating cholinergic symptoms of Alzheimer's disease and Down syndrome. Its ol-202 is used for treating stroke and traumatic brain injury. The company was founded in 2005 and is headquartered in St. Louis, Missouri.
Edunn Biotechnology, Inc.
SaintLouis,Missouri,United States of America
less than 15 people
January 01, 2005
--
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios